The Crystal Mortar Awards (International Drug Chemistry Conference R&D Awards) ceremony will be held for the 7th time on the opening day of the 14th International Drug Chemistry Conference, scheduled for Thursday, February 5, 2026.
On behalf of the 14th International Drug Chemistry Conference family, we extend our heartfelt congratulations to the award-winning companies and look forward to welcoming you at the opening ceremony to receive your awards.
The awards have been determined across eight categories. The first two categories are special awards designated by the Organizing Committee of the Conference, while the other six categories are based on the 2024 R&D Centers Data published by Turkishtime (*https://turkishtimedergi.com/arge500/index.html). The categories and the names of the award-winning pharmaceutical companies are listed below.
Recognizing Excellence in Industry Scientific Publications
To emphasize the pharmaceutical industry’s contributions to science and its role in driving innovation, the Congress Organizing Committee introduced this award category for the first time in 2025. Following its successful launch, the award will continue in 2026 to honor outstanding scientific publications by the pharmaceutical industry. Winners will be announced on the website on January 05, 2026.
Award Criteria:
- Publications must be authored or co-authored by pharmaceutical industry professionals, and must include the company address.
- Evaluations will consider the journal’s impact factor (based on Web of Science: https://wos-journal.info/) and the publication’s relevance and contribution to scientific and technological advancements.
- Eligible publications must have been published 2024-2025.
- Each company’s best publication will be evaluated.
- A company can receive only one award in this category.
- The top three companies meeting the criteria will be recognized.
Submission Details:
To submit your publication for consideration, please complete the required form and submit it by December 31, 2025. Let us celebrate the remarkable achievements of industry researchers and inspire continued excellence in scientific innovation!
Crystal Mortar Award 2026-Winners
Active Pharmaceutical Ingredient (API) Manufacturers (Congress Special Award)
DEVA Holding A.Ş., Ulkar Kimya San. ve Tic. A.Ş., Atabay Kimya San. ve Tic. A.Ş., Polifarma İlaç San. ve Tic. A.Ş.
2024 Pharmaceutical R&D Expenditures
1. DEVA Holding A.Ş. (1.123.509.056 TL)
2. Abdi İbrahim İlaç San. ve Tic. A.Ş. (491.842.973 TL)
3. Hektaş Ticaret Türk A.Ş. (386.142.083 TL)
2024 Pharmaceutical R&D Number of Projects
1. World Medicine İlaç San. ve Tic. A.Ş. (568)
2. DEVA Holding A.Ş. (277)
3. Vem İlaç San. ve Tic.A.Ş. (141)
2024 Pharmaceutical R&D Female Personnel Number
1. DEVA Holding A.Ş. (321)
2. Nobel İlaç San. ve Tic. A.Ş. (102)
3. Bilim İlaç San. ve Tic. A.Ş. (93)
2024 Pharmaceutical R&D Number of Personnels with MSc & PhD Degrees
1. DEVA Holding A.Ş. (67)
2. Abdi İbrahim İlaç San. ve Tic. A.Ş. (58)
3. World Medicine İlaç San. ve Tic. A.Ş. (49)
2024 Pharmaceutical R&D Number of National Patents
1. Sanovel İlaç San. Tic. A.Ş. (6)
2. Santa Farma İlaç San. A.Ş. (4)
2024 Pharmaceutical R&D Number of Brands
1. World Medicine İlaç San. ve Tic. A.Ş. (171)
2. Sanovel İlaç San. Tic. A.Ş. (115)
3. Ali Raif İlaç San. A.Ş. (96)
Source: Turkishtime, R&D Centers 2024 Data, https://turkishtimedergi.com/arge500/index.html
For inquiries, please contact us at iletisim@ilackongresi.org.
Disclaimer: The Organizing Committee reserves the right to make changes to the award categories, criteria, or announced winners if deemed necessary.